Grb10 Interacts Differentially with the Insulin Receptor, Insulin-like Growth Factor I Receptor, and Epidermal Growth Factor Receptor via the Grb10 Src Homology 2 (SH2) Domain and a Second Novel Domain Located between the Pleckstrin Homology and SH2 Domains*

The Grb10 protein appears to be an adapter protein of unknown function that has been implicated in insulin receptor (IR) signaling. The interaction of this protein with the IR has been shown to be mediated in part by the Src homology 2 (SH2) domain of Grb10. Here we demonstrate the existence of a second novel domain within Grb10 that interacts with the IR and insulin-like growth factor receptor in a kinase-dependent manner. This domain was localized to a region of approximately 50 amino acids, and we term it the BPS domain to denote its location between thePH and SH2 domains. The BPS domain does not bear any obvious resemblance to other known protein interaction domains but is highly conserved among the Grb10-related proteins Grb7 and Grb14. We show that the BPS domain interaction is dependent upon receptor tyrosine kinase activity. Furthermore, interaction of the BPS domain requires the kinase domain of the IR, since mutation of the paired tyrosine residues (Y1150F/Y1151F) within the IR activation loop dramatically reduced the interaction. Last, our data suggest that the presence of two distinct protein interaction domains may help to determine the specificity by which Grb10 interacts with different receptors. Specifically, the IR, which appears to interact most strongly with Grb10, interacts well with both the SH2 and BPS domains. Conversely, the insulin-like growth factor receptor and EGFR, which interact less avidly with Grb10, interact well only with the BPS domain or the SH2 domain, respectively. In summary, our findings demonstrate the existence of a previously unidentified tyrosine kinase activity-dependent binding domain located between the Pleckstrin homology and SH2 domains of Grb10.

[1]  S. Hubbard.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog , 1997, The EMBO journal.

[2]  J. Ooi,et al.  The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts. , 1997, The Journal of clinical investigation.

[3]  S. Shoelson,et al.  Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. , 1997, The Journal of biological chemistry.

[4]  J. Olefsky,et al.  Interaction of a GRB-IR Splice Variant (a Human GRB10 Homolog) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.

[5]  B. Margolis,et al.  Grb10: A new substrate of the insulin-like growth factor I receptor. , 1996, Cancer research.

[6]  G M Sanderson,et al.  Cloning and Characterization of GRB14, a Novel Member of the GRB7 Gene Family (*) , 1996, The Journal of Biological Chemistry.

[7]  Ling-mei Wang,et al.  Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.

[8]  F. Giorgino,et al.  Interaction between the Grb10 SH2 Domain and the Insulin Receptor Carboxyl Terminus (*) , 1996, The Journal of Biological Chemistry.

[9]  E. Van Obberghen,et al.  Insulin Receptor Substrate-2 Binds to the Insulin Receptor through Its Phosphotyrosine-binding Domain and through a Newly Identified Domain Comprising Amino Acids 591786 (*) , 1996, The Journal of Biological Chemistry.

[10]  S. Harrison,et al.  Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2 , 1996, Nature.

[11]  R. Roth,et al.  Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Maa,et al.  Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. O’Neill,et al.  Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor (*) , 1995, The Journal of Biological Chemistry.

[14]  A. Craparo,et al.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain , 1995, Molecular and cellular biology.

[15]  C. Roberts,et al.  Mutation of a Conserved Amino Acid Residue (Tryptophan 1173) in the Tyrosine Kinase Domain of the IGF-I Receptor Abolishes Autophosphorylation but Does Not Eliminate Biologic Function (*) , 1995, The Journal of Biological Chemistry.

[16]  S. Hubbard,et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.

[17]  A. Butte,et al.  Insulin receptor substrate 1 mediates the stimulatory effect of insulin on GLUT4 translocation in transfected rat adipose cells. , 1994, The Journal of biological chemistry.

[18]  L. Cantley,et al.  Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression , 1994, Molecular and cellular biology.

[19]  T. O’Neill,et al.  Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system , 1994, Molecular and cellular biology.

[20]  S. Shoelson,et al.  Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. , 1994, The Journal of biological chemistry.

[21]  T. Kitamura,et al.  1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Van Obberghen,et al.  Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. , 1994, European journal of biochemistry.

[23]  J. Olefsky,et al.  Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. , 1994, The Journal of biological chemistry.

[24]  P. D’Eustachio,et al.  The SH2 domain protein GRB‐7 is co‐amplified, overexpressed and in a tight complex with HER2 in breast cancer. , 1994, The EMBO journal.

[25]  R. Medema,et al.  Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras , 1994, Molecular and cellular biology.

[26]  M. Nakafuku,et al.  Signal transduction pathways from insulin receptors to Ras. Analysis by mutant insulin receptors. , 1994, The Journal of biological chemistry.

[27]  T. Okada,et al.  Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. , 1994, The Journal of biological chemistry.

[28]  J. Olefsky,et al.  Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Backer,et al.  Direct activation of the phosphatidylinositol 3'-kinase by the insulin receptor. , 1994, The Journal of biological chemistry.

[30]  M. White,et al.  Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 , 1993, Molecular and cellular biology.

[31]  Roger Brent,et al.  C dil, a Human Gl and S Phase Protein Phosphatase That Associates with Cdk2 , 2003 .

[32]  C. Kahn,et al.  Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Ullrich,et al.  The SH2/SH3 domain‐containing protein GRB2 interacts with tyrosine‐phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. , 1993, The EMBO journal.

[34]  M. White,et al.  Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells. , 1993, The Journal of biological chemistry.

[35]  T. Pawson,et al.  Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. , 1993, The Journal of biological chemistry.

[36]  J. Schlessinger,et al.  Specific phosphopeptide binding regulates a conformational change in the PI 3‐kinase SH2 domain associated with enzyme activation. , 1993, The EMBO journal.

[37]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[38]  A. Ullrich,et al.  High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Brent,et al.  Fused protein domains inhibit DNA binding by LexA , 1992, Molecular and cellular biology.

[40]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[41]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[42]  W. Rutter,et al.  Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Kahn,et al.  A Cascade of Tyrosine Autophosphorylation in the &Subunit Activates the Phosphotransferase of the Insulin Receptor* , 2001 .

[44]  Janina Maier,et al.  Guide to yeast genetics and molecular biology. , 1991, Methods in enzymology.

[45]  Thomas A. Kunkel,et al.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Breeden,et al.  Regulation of the yeast HO gene. , 1985, Cold Spring Harbor symposia on quantitative biology.

[47]  Jeffrey H. Miller.  Experiments in molecular genetics , 1972 .